Implican
2 known investors
Implican is developing a patented anastomotic device that uses two compression rings to fixate bowel walls during colorectal surgery, aiming to achieve primary wound healing and reduce anastomotic leakage. The device targets surgeons treating colorectal cancer patients as an alternative to circular staplers, and is in preclinical/clinical testing.
Founders & leadership
Investors · 2
In the news
Frequently asked questions
- What does Implican do?
- Implican is developing a patented anastomotic device that uses two compression rings to fixate bowel walls during colorectal surgery, aiming to achieve primary wound healing and reduce anastomotic leakage. The device targets surgeons treating colorectal cancer patients as an alternative to circular staplers, and is in preclinical/clinical testing.
- Who are Implican's investors?
- Implican's investors include NV NOM, Nom.